Peptide hormones are a type of signaling molecules that play a crucial role in regulating various physiological functions in the human body. They are synthesized and secreted by endocrine glands scattered throughout the body and consist of amino acids. These hormones control functions such as development, metabolism, reproduction, and stress response. Recently, a new peptide hormone called preptin has been discovered, which is synthesized mainly in the pancreas by beta cells.
Preptin is part of a broader hormone family that includes insulin, amylin, and pramlintide. Its primary function seems to be amplifying the actions of insulin. This is particularly significant because type 2 diabetes is characterized by insulin resistance, which means that the body cannot use insulin effectively. Understanding how preptin and type 2 diabetes interact could lead to the development of novel treatments and prevention methods.
Since preptin is a relatively new discovery, research is still ongoing to understand its functions fully. However, initial studies have shown promising results, and it is believed that preptin could play a significant role in regulating glucose metabolism. Further research is necessary to determine how preptin can be used to treat or prevent type 2 diabetes and other metabolic diseases.
In conclusion, peptide hormones are essential signaling molecules that regulate various physiological functions in the human body. Preptin is a newly discovered hormone that appears to be involved in amplifying the actions of insulin. Understanding the role of preptin in glucose metabolism and type 2 diabetes could lead to the development of new treatments and prevention methods for these diseases.
Author(s) Details:
K. A. Arul Senghor,
Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.
V. M. Vinodhni,
Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.
P. Renuka,
Department of Biochemistry, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603203, Kanchipuram, Chennai, Tamil Nadu, India.
S. Rooban,
SRM Medical College Hospital and Research Centre, SRM IST, Chengalpattu, Tamil Nadu, India.
Please see the link here: https://stm.bookpi.org/ACPR-V4/article/view/12925
Keywords: Signaling molecules, type 2 diabetes, metabolic disorders, glucose stimulation
